We provide consulting services in a number of areas including:
- generation of phosphospecific antibodies and other modification-specific antibodies
- generation of highly selective peptide-derived antibodies against various proteins
- expertise on signal transduction, in particular signaling and regulation of receptor tyrosine kinases, both under normal physiological conditions and as oncogenic mutants in cancer
- advisors to the pharmaceutical industries when it comes to questions regarding cytokines and growth factors and targeted inhibitors of tyrosine kinases and other kinases.
- expert witness in patent litigation trials regarding drugs targeting oncogenic tyrosine kinases and similar pathways (experience from two patent litigation trials in Canada regarding the patent covering the use of Gleevec (imatinib) in 2013
- advise on writing a competitive research proposal. We have extensive experience from both writing proposals and evaluating them for a number of funding organizations
- evaluation of research proposals relating to cancer, growth factors, cytokines, receptor tyrosine kinases, melanoma, acute myeloid leukemia etc.
Contact us for a quote!